NEW YORK CROHNS AND COLITIS ORGANIZATION INC (EIN 812810513) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2016

Legal Domicile

Principal Officer

KEITH SULTAN MD

Phone

7184064358

Tax Period

2023-01-01 to 2023-12-31

NEW YORK CROHNS AND COLITIS ORGANIZATION INC, founded in 2016, is a micro nonprofit in the Diseases & Disorders sector that reported $81K in total revenue in fiscal year 2023. Expenses of $149K exceeded revenue, resulting in a 84% operating deficit.

Mission

NYCCO IS ORGANIZED TO CONDUCT, HAVE PUBLISHED, AND DISTRIBUTE RESEARCH, STUDIES, AND ANALYSIS RELATING TO IBD. TO THAT END, NYCCO SEEKS TO ENHANCE THE LEVEL OF CARE FOR PATIENTS IN THE NEW YORK METROPOLITAN AREA SUFFERING FROM IBD, THROUGH COLLABORATIVE AND TRANSLATIONAL RESEARCH AND IMPROVED COOPERATION AMONGST IBD CLINICIANS IN THE NEW YORK AREA. NYCCO CAN BETTER ACHIEVE THIS GOAL BY GENERATING PUBLIC INTEREST IN IMPROVING TREATMENTS OR FINDING A CURE FOR THE DISEASE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $80,500

Program Service Revenue $0

Investment Income $70

Other Revenue $0

TOTAL REVENUE $80,570

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $145,000

Other Expenses $148,642

TOTAL EXPENSES $148,642

Year-over-Year Comparison

	2023	2022	Change
Revenue	$80,570	$77,985	+0.0%
Expenses	$148,642	$2,926	+49.8%
Net Income	$-68,072	$75,059	-1.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KEITH SULTAN MD	PRESIDENT	4.00	Officer Director	$0	$0	$0
ROBERT HIRTEN MD	VICE PRESIDE	4.00	Officer Director	$0	$0	$0
JORDAN AXELRAD MD	TREASURER	4.00	Officer Director	$0	$0	$0
MANASI AGRAWAL MD	SECRETARY	4.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$80,570	$148,642	$80,293	$-68,072
2022	$77,985	$2,926	$148,365	$75,059
2021	$31	$44,883	$73,306	$-44,852
2020	$45,059	$4,094	$118,158	$40,965
2019	$40,035	$10,059	$77,193	$29,976
2018	$50,006	$3,889	$47,217	$46,117

NEW YORK CROHNS AND COLITIS ORGANIZATION INC